SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-25-004431
Filing Date
2025-01-10
Accepted
2025-01-10 16:03:56
Documents
15
Period of Report
2025-01-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d924537d8k.htm   iXBRL 8-K 26513
2 EX-99.1 d924537dex991.htm EX-99.1 27075
6 GRAPHIC g924537g0110194333458.jpg GRAPHIC 2560
  Complete submission text file 0001193125-25-004431.txt   191911

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crgx-20250110.xsd EX-101.SCH 2841
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crgx-20250110_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crgx-20250110_pre.xml EX-101.PRE 11701
17 EXTRACTED XBRL INSTANCE DOCUMENT d924537d8k_htm.xml XML 3771
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-499-8950
CARGO Therapeutics, Inc. (Filer) CIK: 0001966494 (see all company filings)

IRS No.: 844080422 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41859 | Film No.: 25522846
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)